BRIEF published on 02/17/2026 at 08:35, 7 months ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
BRIEF published on 02/17/2026 at 08:35, 7 months ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
PRESS RELEASE published on 02/17/2026 at 08:30, 7 months ago Inventiva reports preliminary 2025¹ fiscal year financial results Inventiva reports preliminary 2025 fiscal year financial results, showing €99.3 million in cash, €131.6 million in short-term deposits, and €4.5 million in revenues Revenues Financial Results Clinical-stage Inventiva Cash Equivalents
BRIEF published on 02/04/2026 at 22:05, 7 months 13 days ago Inventiva at the Guggenheim Biotech Summit 2026 New York Inventiva MASH Lanifibranor Biotech Summit
BRIEF published on 02/04/2026 at 22:05, 7 months 13 days ago Inventiva to Participate in Guggenheim Biotech Summit 2026 Biopharmaceuticals Inventiva MASH Lanifibranor Biotech Summit
PRESS RELEASE published on 02/04/2026 at 22:00, 7 months 13 days ago Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Inventiva to present at Guggenheim Emerging Outlook: Biotech Summit 2026. CEO Andrew Obenshain to participate in fireside chat on February 11, 2026, in New York City Fireside Chat Inventiva Biotech Summit Guggenheim Emerging Outlook CEO Andrew Obenshain
BRIEF published on 01/30/2026 at 11:21, 7 months 18 days ago JP Morgan Chase & Co.'s reduced stake in INVENTIVA Shares Threshold Crossing Right To Vote JP Morgan Inventiva
BRIEF published on 01/26/2026 at 22:05, 7 months 22 days ago Inventiva's Liquidity Contract with Kepler Cheuvreux: Half-Year Update Liquidity Contract Kepler Cheuvreux Biopharmaceutical Inventiva MASH
PRESS RELEASE published on 01/26/2026 at 22:00, 7 months 22 days ago Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux Inventiva's half-year review of liquidity contract with Kepler Cheuvreux reveals cash & share details as of Dec 2025, showing increase from previous report Liquidity Contract Kepler Cheuvreux Financial Report Biopharmaceutical Inventiva
BRIEF published on 01/20/2026 at 15:57, 7 months 28 days ago JP Morgan crosses thresholds in INVENTIVA's capital Actions Stock Market Crossing Thresholds JP Morgan Inventiva
Published on 09/18/2026 at 00:55, 2 hours 1 minute ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 2 hours 31 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 4 hours 41 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 4 hours 51 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 19:00, 7 hours 56 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 7 hours 57 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 8 hours 31 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 8 hours 46 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 9 hours 10 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 9 hours 16 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 9 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 19 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
